BioCentury
ARTICLE | Clinical News

Aironite: Phase IIa started

March 2, 2015 8:00 AM UTC

Mast said the Mayo Clinic began a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate 90 mg inhaled AIR001 in about 30 patients. ...